-
-
-
-
-
-
-
Ultragenyx Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application (BLA) for DTX401 AAV Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)
-
-
-
-
-
-
-
TD Cowen's Best Smidcap Ideas 2025
-
-
-
-
-
-
-
Ultragenyx Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Update
-
-
-
-
-
-
-
Ultragenyx Pharma (RARE) PT Raised to $90 at Jefferies
-
-
-
-
-
-
-
Ultragenyx Reports Fourth Quarter and Full Year 2019 Financial Results and Corporate Update
-
-
-
-
-
-
-
Ultragenyx Announces FDA Accepts New Drug Application for UX007 (triheptanoin) for Treatment of Long-chain Fatty Acid Oxidation Disorders
-
-
-
-
-
-
-
Ultragenyx Reports Fourth Quarter and Full Year 2017 Financial Results and Corporate Update
-
15,464 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

